tiprankstipranks
Trending News
More News >
OncoArendi Therapeutics SA (PL:MOC)
:MOC
Poland Market

OncoArendi Therapeutics SA (MOC) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
OncoArendi Therapeutics SA’s (MOC) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting OncoArendi Therapeutics SA is a Buy.
OncoArendi Therapeutics SA’s (MOC) 20-Day exponential moving average is 7.32, while OncoArendi Therapeutics SA’s (MOC) share price is zł7.39, making it a Buy.
OncoArendi Therapeutics SA’s (MOC) 50-Day exponential moving average is 7.16, while OncoArendi Therapeutics SA’s (MOC) share price is zł7.39, making it a Buy.

OncoArendi Therapeutics SA (MOC) Pivot Points

Feb 13, 2026, 06:06 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.65
6.88
7.11
7.34
7.57
7.80
8.03
Fibonacci
6.88
7.05
7.16
7.34
7.51
7.62
7.80
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

OncoArendi Therapeutics SA (MOC) Moving Averages

Feb 13, 2026, 06:06 PM
Period
Simple
Exponential
MA5
7.08Buy
7.26Buy
MA10
7.46Sell
7.32Buy
MA20
7.40Sell
7.32Buy
MA50
7.10Buy
7.16Buy
MA100
7.00Buy
7.11Buy
MA200
7.03Buy
7.30Buy
OncoArendi Therapeutics SA’s (MOC) 10-Day exponential moving average is 7.32, while OncoArendi Therapeutics SA’s (MOC) share price is zł7.39, making it a Buy.
OncoArendi Therapeutics SA’s (MOC) 100-Day exponential moving average is 7.11, while OncoArendi Therapeutics SA’s (MOC) share price is zł7.39, making it a Buy.
OncoArendi Therapeutics SA’s (MOC) stock price is zł7.39 and OncoArendi Therapeutics SA’s (MOC) 50-day simple moving average is 7.10, creating a Buy signal.
OncoArendi Therapeutics SA’s (MOC) stock price is zł7.39 and OncoArendi Therapeutics SA’s (MOC) 100-day simple moving average is 7.00, creating a Buy signal.
OncoArendi Therapeutics SA’s (MOC) stock price is zł7.39 and OncoArendi Therapeutics SA’s (MOC) 200-day simple moving average is 7.03, creating a Buy signal.

OncoArendi Therapeutics SA (MOC) Technical Indicators

Feb 13, 2026, 06:06 PM
Name
Value
Implied Action
RSI (14)
51.93
Neutral
STOCH (9,6)
29.98
Neutral
STOCHRSI (14)
28.65
Neutral
MACD (12,26)
0.04
Buy
ADX (14)
16.95
Buy
Williams %R
-66.27
Buy
CCI (14)
-11.27
Neutral
ATR (14)
0.47
-
Ultimate Oscillator
50.84
Neutral
ROC
3.07
Buy
OncoArendi Therapeutics SA’s (MOC) Relative Strength Index (RSI) is 51.93, creating a Neutral signal.
OncoArendi Therapeutics SA’s (MOC) Trend Strength Indicator (ADX) is 16.95, creating a Buy signal.
OncoArendi Therapeutics SA’s (MOC) Commodity Channel Index (CCI) is -11.27, creating a Neutral signal.
OncoArendi Therapeutics SA’s (MOC) Price Rate of Change (ROC) is 3.07, creating a Buy signal.

FAQ

Is MOC a Buy, Hold, or Sell?
Based on MOC’s technical indicators, MOC is a Buy.
    What is MOC’s RSI (14)?
    MOC’s RSI (14) is 51.93, which suggests MOC is a Neutral.
      What is MOC’s MACD?
      MOC’s MACD is 0.04, which suggests MOC is a Buy.
        What is MOC’s 5-day moving average?
        MOC’s 5-day moving average is 7.08, which suggests MOC is a Buy.
          What is MOC’s 20-day moving average?
          MOC 20-day moving average is 7.40, which suggests MOC is a Sell.
            What is MOC’s 50-day moving average?
            MOC’s 50-day moving average is 7.10, which suggests MOC is a Buy.
              What is MOC’s 200-day moving average?
              MOC’s 200-day moving average is 7.03, which suggests MOC is a Buy.
                What is MOC’s Williams % R (14)?
                MOC’s Williams % R (14) is -66.27, which suggests MOC is a Buy.
                  What is MOC’s CCI (14)?
                  MOC’s CCI (14) is -11.27, which suggests MOC is a Neutral.
                    What is the share price of OncoArendi Therapeutics SA?